The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcome analysis of non-high-risk neuroblastoma patients enrolled on Children’s Oncology Group trials P9641 and A3961.
Holly Jane Meany
No relevant relationships to disclose
Edward F. Attiyeh
No relevant relationships to disclose
Arlene Naranjo
No relevant relationships to disclose
Clare Twist
No relevant relationships to disclose
Wendy B. London
No relevant relationships to disclose
Judith Villablanca
No relevant relationships to disclose
Mary Lou Schmidt
No relevant relationships to disclose
Dave Baker
No relevant relationships to disclose
Douglas R. Strother
No relevant relationships to disclose
Hiroyuki Shimada
No relevant relationships to disclose
Katherine K. Matthay
No relevant relationships to disclose
Susan Lerner Cohn
No relevant relationships to disclose
John M. Maris
No relevant relationships to disclose
Julie R. Park
No relevant relationships to disclose